Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018 Keiichiro TadaHiraku KumamaruHiromitsu Jinno Special Article Open access 22 December 2022 Pages: 157 - 166
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches Hong-My NguyenWyatt PaulishakLaurence Wood Review Article 18 November 2022 Pages: 167 - 186
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options Karolina AnuszkiewiczJerzy JankauMartyna Kur Review Article Open access 26 December 2022 Pages: 187 - 199
Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients Mohammed Tarek HasanMohamed HamoudaMohamed Ibrahim Gbreel Review Article Open access 09 January 2023 Pages: 200 - 214
Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors Stacyann BaileyCharlotte EzrattyJenny J. Lin Original Article 01 November 2022 Pages: 215 - 225
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up Sriyani Padmalatha Konara MudiyanselageYi-Lin WuNai-Ying Ko Original Article 01 November 2022 Pages: 226 - 240
Performance analysis of screening mammography in Asian women under 40 years Mi-ri KwonYoosoo ChangShin Ho Kook Original Article 05 November 2022 Pages: 241 - 248
A cost-consequences analysis of the SAFE trial: a comparative, effectiveness trial evaluating high- versus low-supervision of an exercise intervention for women with breast cancer Jessica T. WatzekLouisa G. GordonSandra C. Hayes Original Article 03 December 2022 Pages: 249 - 258
High PPFIA1 expression promotes cancer survival by suppressing CD8+ T cells in breast cancer: drug discovery and machine learning approach Jinah ChuKyueng-Whan MinSung-Im Do Original Article 07 December 2022 Pages: 259 - 270
Predictors of persistent post-surgical pain intensity and interference at 1 year after breast cancer surgery: assessing central sensitization, central sensitivity symptoms, and psychological factors Masahiro ManfukuTomohiko NishigamiKazuhiro Sumiyoshi Original Article 18 December 2022 Pages: 271 - 281
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study Terufumi KawamotoNaoto ShikamaNaoki Nakamura Original Article 17 December 2022 Pages: 282 - 292
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04) Manabu FutamuraKazuhiro IshiharaNobuhisa Matsuhasih Original Article Open access 07 January 2023 Pages: 293 - 301
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan Rena YamakadoMakoto IshitobiCollaborative Study Group of Scientific Research of the Japanese Breast Cancer Society Original Article 17 December 2022 Pages: 302 - 308
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study Tomoe TajiNina OdanHirofumi Suwa Original Article 22 December 2022 Pages: 309 - 314
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients Caroline BailleuxAntoine ArnaudPierre-Etienne Heudel Original Article Open access 05 January 2023 Pages: 315 - 328
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort Laetitia ColletLauriane EberstThomas Bachelot Original Article 11 January 2023 Pages: 329 - 341
